Dyspnea and Inhaled Corticosteroid and Long-acting β-Agonist Therapy in an Occupational Cohort: A Longitudinal Study.
作者信息
Putman Barbara, Lahousse Lies, Singh Ankura, Zeig-Owens Rachel, Hall Charles B, Fazzari Melissa J, Schwartz Theresa, Webber Mayris P, Cohen Hillel W, Prezant David J, Weiden Michael D
机构信息
New York University School of MedicineNew York, New York.
Ghent UniversityGhent, Belgium.
出版信息
Ann Am Thorac Soc. 2020 Jun;17(6):770-773. doi: 10.1513/AnnalsATS.201910-794RL.
Abstract
摘要
相似文献
1
Dyspnea and Inhaled Corticosteroid and Long-acting β-Agonist Therapy in an Occupational Cohort: A Longitudinal Study.职业队列中呼吸困难与吸入性糖皮质激素及长效β受体激动剂治疗：一项纵向研究
Ann Am Thorac Soc. 2020 Jun;17(6):770-773. doi: 10.1513/AnnalsATS.201910-794RL.
2
When should a long acting {beta} agonist be added to an inhaled corticosteroid?长效β受体激动剂应在何时添加到吸入性糖皮质激素中？
Thorax. 2005 Sep;60(9):710. doi: 10.1136/thx.2005.042028.
3
Rescue treatment in asthma. More than as-needed bronchodilation.哮喘的救援治疗。不止是按需支气管扩张。
Chest. 2009 Jun;135(6):1628-1633. doi: 10.1378/chest.08-2536.
4
5
Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.长效β-激动剂和吸入性皮质类固醇联合治疗与长效β-激动剂单药治疗在老年慢性阻塞性肺疾病患者中的比较。
JAMA. 2014 Sep 17;312(11):1114-21. doi: 10.1001/jama.2014.11432.
6
Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.慢性阻塞性肺疾病的药物治疗：一项混合治疗比较的荟萃分析。
Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.
7
What to do at step 3 of the asthma guidelines-increase the dose of inhaled corticosteroids or add a long-acting beta-agonist drug?哮喘指南第三步该怎么做——增加吸入性糖皮质激素剂量还是添加长效β受体激动剂药物？
J Allergy Clin Immunol. 2003 Jul;112(1):10-1. doi: 10.1067/mai.2003.1589.
8
Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease.皮质类固醇与β2受体激动剂在哮喘和慢性阻塞性肺疾病中的相互作用。
Proc Am Thorac Soc. 2004;1(3):200-6. doi: 10.1513/pats.200402-010MS.
9
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.长效吸入型β受体激动剂支气管扩张剂与吸入性糖皮质激素联合使用时的安全性和有效性。
Ann Intern Med. 2006 Nov 7;145(9):692-4. doi: 10.7326/0003-4819-145-9-200611070-00012.
10
Intermittent steroid inhalation for the treatment of childhood asthma.间歇性吸入类固醇治疗儿童哮喘。
Expert Rev Clin Immunol. 2016;12(2):183-94. doi: 10.1586/1744666X.2016.1105741. Epub 2015 Nov 11.
引用本文的文献
1
Association of Lung Function Decline with All-Cause and Cancer-Cause Mortality after World Trade Center Dust Exposure.接触世界贸易中心粉尘后肺功能下降与全因和癌症死亡率的关联。
Ann Am Thorac Soc. 2023 Aug;20(8):1136-1143. doi: 10.1513/AnnalsATS.202212-1011OC.
2
Twenty-Year Reflection on the Impact of World Trade Center Exposure on Pulmonary Outcomes in Fire Department of the City of New York (FDNY) Rescue and Recovery Workers.二十年来世贸中心暴露事件对纽约市消防局（FDNY）救援和恢复工作人员肺部健康影响的反思。
Lung. 2021 Dec;199(6):569-578. doi: 10.1007/s00408-021-00493-z. Epub 2021 Nov 11.
3
Serum Th-2 cytokines and FEV decline in WTC-exposed firefighters: A 19-year longitudinal study.血清 Th-2 细胞因子与接触世贸中心消防员的 FEV 下降：一项 19 年的纵向研究。
Am J Ind Med. 2021 Oct;64(10):845-852. doi: 10.1002/ajim.23276. Epub 2021 Jul 20.
4
Lung function decline before and after treatment of World Trade Center associated obstructive airways disease with inhaled corticosteroids and long-acting beta agonists.世贸中心相关阻塞性气道疾病经吸入皮质类固醇和长效β激动剂治疗前后的肺功能下降。
Am J Ind Med. 2021 Oct;64(10):853-860. doi: 10.1002/ajim.23272. Epub 2021 Jul 13.
5
Factors Predicting Treatment of World Trade Center-Related Lung Injury: A Longitudinal Cohort Study.预测与世界贸易中心相关肺损伤治疗的因素：一项纵向队列研究。
Int J Environ Res Public Health. 2020 Dec 4;17(23):9056. doi: 10.3390/ijerph17239056.
本文引用的文献
1
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.全球慢性阻塞性肺疾病诊断、管理和预防策略：GOLD 科学委员会报告 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.
2
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.血液嗜酸性粒细胞：吸入性糖皮质激素降低慢性阻塞性肺疾病急性加重的生物标志物。
Int J Chron Obstruct Pulmon Dis. 2018 Nov 6;13:3669-3676. doi: 10.2147/COPD.S179425. eCollection 2018.
3
Predictors of Asthma/COPD Overlap in FDNY Firefighters With World Trade Center Dust Exposure: A Longitudinal Study.有世界贸易中心粉尘暴露史的 FDNY 消防员哮喘/COPD 重叠的预测因素：一项纵向研究。
Chest. 2018 Dec;154(6):1301-1310. doi: 10.1016/j.chest.2018.07.002. Epub 2018 Jul 17.
4
Blood Leukocyte Concentrations, FEV Decline, and Airflow Limitation. A 15-Year Longitudinal Study of World Trade Center-exposed Firefighters.血液白细胞浓度、FEV 下降和气流受限。暴露于世界贸易中心的消防员的 15 年纵向研究。
Ann Am Thorac Soc. 2018 Feb;15(2):173-183. doi: 10.1513/AnnalsATS.201703-276OC.
5
A summary of the new GINA strategy: a roadmap to asthma control.新全球哮喘防治创议（GINA）策略总结：哮喘控制路线图
Eur Respir J. 2015 Sep;46(3):622-39. doi: 10.1183/13993003.00853-2015. Epub 2015 Jul 23.
6
Trends in respiratory diagnoses and symptoms of firefighters exposed to the World Trade Center disaster: 2005-2010.2005-2010 年暴露于“世界贸易中心灾难”的消防员的呼吸诊断和症状趋势。
Prev Med. 2011 Dec;53(6):364-9. doi: 10.1016/j.ypmed.2011.09.001. Epub 2011 Sep 10.
7
Lung function in rescue workers at the World Trade Center after 7 years.世界贸易中心救援人员 7 年后的肺功能。
N Engl J Med. 2010 Apr 8;362(14):1263-72. doi: 10.1056/NEJMoa0910087.
8
Obstructive airways disease with air trapping among firefighters exposed to World Trade Center dust.消防员接触世界贸易中心粉尘导致的气道阻塞性疾病和空气滞留。
Chest. 2010 Mar;137(3):566-74. doi: 10.1378/chest.09-1580. Epub 2009 Oct 9.
9
Trends in respiratory symptoms of firefighters exposed to the world trade center disaster: 2001-2005.2001 - 2005年世贸中心灾难事件中消防员呼吸道症状的变化趋势
Environ Health Perspect. 2009 Jun;117(6):975-80. doi: 10.1289/ehp.0800291. Epub 2009 Feb 11.
10
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.沙美特罗与丙酸氟替卡松及慢性阻塞性肺疾病患者的生存率
N Engl J Med. 2007 Feb 22;356(8):775-89. doi: 10.1056/NEJMoa063070.
Zotero 插件